Physician profile
Anthony Bentley
NPI 1316919855
$6,982.45
in general payments reported to CMS, 2019-2025
16 companies · $919 in 2025
The $919 reported for 2025 was more than what 78% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $211 · 2020: $77.66 · 2021: $1,247 · 2022: $2,622 · 2023: $1,090 · 2024: $816 · 2025: $919.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,811 · Education: $13.76.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,811.42 |
| Education | $13.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $5,740.23 | 2021-2025 | Inspire |
| Stryker Corporation | $449.84 | 2020-2025 | Scopis Ent |
| Olympus America INC. | $157.37 | 2019-2023 | |
| Medtronic, INC. | $127.80 | 2022-2023 | Propel, Nim Vital, Pteye Parathyroid Detection System |
| Intersect Ent, INC. | $92.92 | 2019 | |
| Livanova USA, INC. | $66.92 | 2024 | Vns Therapy Sentiva Model 1000 Generator |
| Glaxosmithkline, LLC. | $53.39 | 2022-2025 | Nucala |
| Medtronic USA, INC. | $51.28 | 2019-2020 | |
| Polynovo North America LLC | $49.61 | 2024-2025 | Novosorb Btm |
| Revance Therapeutics, INC. | $43.63 | 2024 | Daxxify |
| Integra Lifesciences Corporation | $41.08 | 2025 | Inspira Air, Acclarent Aera, Trudi Probe |
| Acclarent, INC | $38.02 | 2024 | Acclarent Aera |
| Merck Sharp & Dohme LLC | $28.37 | 2023 | |
| Novartis Pharmaceuticals Corporation | $14.97 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.76 | 2024 | Eohilia |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $13.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Bentley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.